Jump to main content
Jump to site search

Issue 16, 2009
Previous Article Next Article

Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy

Author affiliations


The tetrahydrosalens N,N′-bis(2-hydroxybenzyl)-ethane-1,2-diamine (H2L1), N,N′-bis(2-hydroxybenzyl)-(−)-1,2-cyclohexane-(1R,2R)-diamine (H2L2), N,N′-bis(2-hydroxybenzyl)-N,N′-dimethyl-ethane-1,2-diamine (H2L3), N,N′-bis(2-hydroxybenzyl)-N,N′-dibenzyl-ethane-1,2-diamine (H2L4), and N,N′-bis(2-(4-tert-butyl)hydroxybenzyl)-ethane-1,2-diamine (H2L5), as well as their prodrug glycosylated forms, GL1–5, have been prepared and evaluated in vitro for their potential use as Alzheimer's disease (AD) therapeutics. Dysfunctional interactions of metal ions, especially those of Cu, Zn, and Fe, with the amyloid-β (Aβ) peptide are hypothesised to play an important role in the aetiology of AD, and disruption of these aberrant metal–peptide interactions via chelation therapy holds considerable promise as a therapeutic strategy. Tetrahydrosalens such as H2L1–5 have a significant affinity for metal ions, and thus should be able to compete with the Aβ peptide for Cu, Zn, and Fe in the brain. This activity was assayed in vitrovia a turbidity assay; H2L1 and H2L3 were found to attenuate 1–40 aggregation after exposure to Cu2+ and Zn2+. In addition, H2L1–5 were determined to be potent antioxidants on the basis of an in vitro antioxidant assay. GL1–5 were prepared as metal binding prodrugs; glycosylation is intended to prevent systemic metal binding, improve solubility, and enhance brain uptake. Enzymatic (β-glucosidase) deprotection of the carbohydrate moieties was facile, with the exception of GL4, demonstrating the general feasibility of this prodrug approach. Finally, a representative prodrug, GL3, was determined to be non-toxic over a large concentration range in a cell viability assay.

Graphical abstract: Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 06 Feb 2009, accepted on 16 Feb 2009 and first published on 05 Mar 2009

Article type: Paper
DOI: 10.1039/B902545F
Citation: Dalton Trans., 2009,0, 3034-3043

  •   Request permissions

    Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy

    T. Storr, L. E. Scott, M. L. Bowen, D. E. Green, K. H. Thompson, H. J. Schugar and C. Orvig, Dalton Trans., 2009, 0, 3034
    DOI: 10.1039/B902545F

Search articles by author